Draft:Dwarfism Awareness Day
Submission declined on 20 November 2023 by MaxnaCarta (talk).
Where to get help
How to improve a draft
You can also browse Wikipedia:Featured articles and Wikipedia:Good articles to find examples of Wikipedia's best writing on topics similar to your proposed article. Improving your odds of a speedy review To improve your odds of a faster review, tag your draft with relevant WikiProject tags using the button below. This will let reviewers know a new draft has been submitted in their area of interest. For instance, if you wrote about a female astronomer, you would want to add the Biography, Astronomy, and Women scientists tags. Editor resources
|  |
| Submission declined on 19 November 2023 by DoubleGrazing (talk). This submission is not adequately supported by reliable sources. Reliable sources are required so that information can be verified. If you need help with referencing, please see Referencing for beginners and Citing sources. This draft's references do not show that the subject qualifies for a Wikipedia article. In summary, the draft needs multiple published sources that are: Declined by DoubleGrazing 6 months ago.
| |
| Submission declined on 18 November 2023 by Vanderwaalforces (talk). This draft's references do not show that the subject qualifies for a Wikipedia article. In summary, the draft needs multiple published sources that are: Declined by Vanderwaalforces 6 months ago.
| |
| Submission declined on 18 November 2023 by WikiOriginal-9 (talk). This draft's references do not show that the subject qualifies for a Wikipedia article. In summary, the draft needs multiple published sources that are: Declined by WikiOriginal-9 6 months ago.
| |
Comment: Not even close to being notable, likely needs to be included elsewhere in an appropriate article — MaxnaCarta ( 💬 • 📝 ) 00:19, 20 November 2023 (UTC)
- Comment: The 'Weblinks' (properly titled 'External links') section is much too long. Pick one or two that are most relevant and close to the subject, and remove the rest. Wikipedia articles are not link portals. DoubleGrazing (talk) 11:33, 19 November 2023 (UTC)
- Comment: Most of the sources make no, or only passing, mentions of Dwarfism Awareness Day. The one that does, is closely associated with the subject. (And LinkedIn doesn't count.) DoubleGrazing (talk) 11:32, 19 November 2023 (UTC)
- Comment: Quite a lot of the content seems to be about topics other than Dwarfism Awareness Day. Please cut out any diversions, ensuring that the draft stays within its topic area. DoubleGrazing (talk) 11:30, 19 November 2023 (UTC)
International Dwarfism Awareness Day[edit]
Individuals with dwarfism and global organizations supporting Little People and their families recognize October 25 as International Dwarfism Awareness Day[1][2].
In various nations[3][4][5][6], those with dwarfism continue to encounter social and physical barriers affecting their choices and opportunities. On this day, Little People join forces to advance awareness of dwarfism and express pride, aiming to confront these barriers and emphasize their right to self-determination and independence.[7][8]
Dwarfism refers to a condition characterized by short stature resulting from either genetic or medical factors. Typically, it is defined as an adult height of less than 4 feet 10 inches (147 centimeters), with Achondroplasia being one of the most recognizable conditions[9]. These disorders can be broadly categorized into two types:
Many dwarfism conditions have a genetic basis and may have a familial tendency. Some disorders may also be associated with additional complications such as vision or hearing issues, spinal problems, etc. Certain conditions may show partial improvement with medication, but it's crucial to undergo a thorough genetic evaluation before pursuing such options. Fortunately, the majority of these conditions do not affect intellectual capabilities, and individuals with dwarfism generally lead healthy lives, functioning normally in various aspects of life.
Utilization of Dwarfism Awareness Day in the Healthcare and Pharmaceutical Industry[edit]
In recent times, there has been a notable surge in medical and pharmaceutical research dedicated to Dwarfism, with a particular emphasis on achondroplasia[10][11]. The healthcare and pharmaceutical sector often utilizes awareness days to focus on specific medical conditions within their business portfolio. These designated days offer companies a chance to highlight particular medical conditions, emphasizing their effects on individuals and communities, and underscoring the importance of research, treatment, and support.
Major pharmaceutical players such as BioMarin Pharmaceutical[12], Pfizer[13], Sanofi[14], and BridgeBio Pharma[15] have made significant strides, with therapies already in the market, undergoing clinical trials, or in the research and development phase. This heightened focus reflects the commitment of these companies to addressing the unique needs of individuals affected by Dwarfism and achondroplasia.[16][17]
External links[edit]
International Observances
Patient Organizations:
Little people UK - International Dwarfism Awareness Day
LPA - Dwarfism Awareness Month
Hospitals and Pharmaceutical Companies:
American Pharmaceutical company: Biomarin acknowledging Dwarfism Awareness Day
References[edit]
- ^ "Events | NHS Local". Archived from the original on 2011-09-26.
- ^ https://www.twinkl.nl/event/dwarfism-awareness-day-2023
- ^ "Dwarfism Awareness Day 2023 | C3SC - Cardiff Third Sector Council". 4 October 2023.
- ^ "Calendar Event - EVENT: Dwarfism Awareness Day 2023 , 25 October 2023". 25 October 2023.
- ^ "Department of Empowerment of Persons with Disabilities observed World Dwarfism Day".
- ^ "Ministry of Health Saudi Arabia".
- ^ https://www.lpaonline.org/dwarfism-awareness-month LPA
- ^ "International Dwarfism Awareness Day!".
- ^ "What is Achondroplasia".
- ^ "Eu/3/21/2454". 11 May 2022.
- ^ "Our Healthcare Pipeline - Research R&D portfolio".
- ^ "VOXZOGO® (Vosoritide) | Our Products".
- ^ "Pfizer Doses First Participants as Part of Global Achondroplasia Phase 2 Development Program | Pfizer".
- ^ "SAR-442501 by Sanofi for Achondroplasia: Likelihood of Approval". 3 March 2023.
- ^ "Low-dose Infigratinib | Achondroplasia".
- ^ "Patient Advocacy | Patient & Community Support".
- ^ https://cdn.pfizer.com/pfizercom/responsibility/EU_Funding/Russia_2020.pdf
- in-depth (not just passing mentions about the subject)
- reliable
- secondary
- independent of the subject
Make sure you add references that meet these criteria before resubmitting. Learn about mistakes to avoid when addressing this issue. If no additional references exist, the subject is not suitable for Wikipedia.